Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Haematologica|July 11, 2024
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant optionsChristos Georgiadis, Lauren Nickolay, Farhatullah Syed, et al.
Science Translational Medicine|October 26, 2022
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemiaGiorgio Ottaviano, Christos Georgiadis, Soragia Athina Gkazi, et al.
The New England Journal of Medicine|June 14, 2023
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic LeukemiaRobert Chiesa, Christos Georgiadis, Farhatullah Syed, et al.
Blood|July 31, 2015
Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1Julien Record, Dessislava Malinova, Helen L Zenner, et al.
The Journal of Investigative Dermatology|January 15, 2016
Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEBChristos Georgiadis, Farhatullah Syed, Anastasia Petrova, et al.
Advanced Functional Materials|June 17, 2022
Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved SurvivalAristides D Tagalakis, Vignesh Jayarajan, Ruhina Maeshima, et al.
Cytotherapy|August 6, 2025
Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle eastAmr Hanbali, Fahad Bahkali, Farhatullah Syed, et al.
Human Gene Therapy|July 11, 2019
Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 TrialWei-Li Di, Su M Lwin, Anastasia Petrova, et al.
Molecular Therapy. Advances|May 15, 2026
A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCLClaire Roddie, Juliana Dias, Gordon Weng-Kit Cheung, et al.
Blood|July 11, 2025
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletionClaire Roddie, Juliana Dias, Maeve O'Reilly, et al.
Pageof 4